Tweet
Hum Vaccin Immunother. 2015 Jun 4:0. [Epub ahead of print]
Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).
Feng L1, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, Zhao G, Yu H.
Author information
Abstract
Influenza, caused by the influenza virus, is a respiratory infectious disease that can severely affect human health. Influenza viruses undergo frequent antigenic changes, thus could spread quickly. Influenza causes seasonal epidemics and outbreaks in public gatherings such as schools, kindergartens, and nursing homes. Certain populations are at risk for severe illness from influenza, including pregnant women, young children, the elderly, and people in any ages with certain chronic diseases. To strengthen the technical guidance for control and prevention of influenza, and to promote influenza vaccination in China, the Chinese Center for Disease Control and Prevention organized a panel of experts to review the latest international studies on influenza vaccination, including the "WHO Position Paper on Influenza Vaccines - November 2012", and to compile the "Technical Guidelines for the Application of Seasonal Influenza Vaccines in China (2014-2015)". The guidelines systematically review the published literatures and unpublished works from the latest influenza research in China, including its etiology, clinical characteristics, laboratory diagnosis, epidemiology, disease burden, types of influenza vaccines, immune response mechanisms, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. On the basis of existing scientific evidence, the guidelines provide recommendations for influenza vaccination in the influenza season of 2014-2015. In China, influenza vaccine is not incliuded in the national immunization program, and recipients shall pay for the vaccine voluntarily out of pocket. Points of Vaccination clinics (POVs) should provide immunization services for all individuals aged six months and above who are willing to be vaccinated and have no contraindications. To decrease the risk of severe complications due to influenza infection, the guidelines recommend annual seasonal influenza vaccines to be administered to pregnant women, children aged 6-59 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, and family members and caregivers of infants <6 months of age. The guidelines can be used by staff of the Centers for Disease Control and Prevention at all levels who engage in influenza control and prevention, POVs staff, healthcare workers in the departments of pediatrics, internal medicine, and infectious diseases in medical institutions, and the staff of maternal and child health institutions. The guidelines will be updated periodically as new evidence becomes available.
PMID: 26042462 [PubMed - as supplied by publisher]
Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).
Feng L1, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, Zhao G, Yu H.
Author information
Abstract
Influenza, caused by the influenza virus, is a respiratory infectious disease that can severely affect human health. Influenza viruses undergo frequent antigenic changes, thus could spread quickly. Influenza causes seasonal epidemics and outbreaks in public gatherings such as schools, kindergartens, and nursing homes. Certain populations are at risk for severe illness from influenza, including pregnant women, young children, the elderly, and people in any ages with certain chronic diseases. To strengthen the technical guidance for control and prevention of influenza, and to promote influenza vaccination in China, the Chinese Center for Disease Control and Prevention organized a panel of experts to review the latest international studies on influenza vaccination, including the "WHO Position Paper on Influenza Vaccines - November 2012", and to compile the "Technical Guidelines for the Application of Seasonal Influenza Vaccines in China (2014-2015)". The guidelines systematically review the published literatures and unpublished works from the latest influenza research in China, including its etiology, clinical characteristics, laboratory diagnosis, epidemiology, disease burden, types of influenza vaccines, immune response mechanisms, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. On the basis of existing scientific evidence, the guidelines provide recommendations for influenza vaccination in the influenza season of 2014-2015. In China, influenza vaccine is not incliuded in the national immunization program, and recipients shall pay for the vaccine voluntarily out of pocket. Points of Vaccination clinics (POVs) should provide immunization services for all individuals aged six months and above who are willing to be vaccinated and have no contraindications. To decrease the risk of severe complications due to influenza infection, the guidelines recommend annual seasonal influenza vaccines to be administered to pregnant women, children aged 6-59 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, and family members and caregivers of infants <6 months of age. The guidelines can be used by staff of the Centers for Disease Control and Prevention at all levels who engage in influenza control and prevention, POVs staff, healthcare workers in the departments of pediatrics, internal medicine, and infectious diseases in medical institutions, and the staff of maternal and child health institutions. The guidelines will be updated periodically as new evidence becomes available.
PMID: 26042462 [PubMed - as supplied by publisher]